Site 0146 - Maryland Oncology Hematology, PA — Rockville, Maryland

Site 0146 - Maryland Oncology Hematology, PA is a clinical research site located in Rockville, Maryland, United States 20876.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site 0146 - Maryland Oncology Hematology, PA has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Sponsors: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Rockville

Browse all research sites in Maryland · View every site in Rockville

• Holy Cross Hospital
• Cardiac Associates, Shady Grove Adventist Hospital
• Biostatistics Center, George Washington University
• Safe Concussion Outcome Recovery & Education (SCORE) Clinic at Children's National Hospital
• George Washington University Biostatistics Center, Suite 750, 6110 Executive Blvd
• George Washington University Biostatistics Center
• Shady Grove Adventist Hospital
• Center for Autism Spectrum Disorders, Children's National Hospital
• George Washington University
• Research Site
• Novo Nordisk Investigational Site
• GSK Investigational Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 0146 - Maryland Oncology Hematology, PA?

Site 0146 - Maryland Oncology Hematology, PA has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 0146 - Maryland Oncology Hematology, PA conducted?

Site 0146 - Maryland Oncology Hematology, PA has 1 clinical trials on record, with 1 currently active. Their work covers High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Is Site 0146 - Maryland Oncology Hematology, PA accredited by Crixeo Clinical Trials?

Site 0146 - Maryland Oncology Hematology, PA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 0146 - Maryland Oncology Hematology, PA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.